Enliven Therapeutics Inc.

19.98
0.12 (0.60%)
At close: Apr 03, 2025, 3:59 PM
20.52
2.72%
After-hours: Apr 03, 2025, 07:32 PM EDT

Enliven Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for ELVN stock have an median target of 39, with a low estimate of 34 and a high estimate of 42. The median target predicts an increase of 95.20% from the current stock price of 19.98.

Target Low Average Median High
Price $34 $38.2 $39 $42
Change 70.17% 91.19% 95.20% 110.21%

Latest Analyst Insight Report

HC Wainwright & Co. has reaffirmed a Buy rating fo... Unlock content with Pro Subscription

Updated Mar 21, 2025

Rating Jun 24Sep 24Oct 24Nov 24Dec 24Mar 25
Strong Buy 000001
Buy 112110
Hold 000000
Sell 000000
Strong Sell 000000
Total 1 1 2 1 1 1

Financial Forecast this Year

Revenue This Year
7.14K
from 0
Increased by -%
Revenue Next Year
8.33K
from 7.14K
Increased by 16.7%
EPS This Year
-2.2
from -1.89
Increased by -16.4%
EPS Next Year
-2.54
from -2.2
Increased by -15.5%